A large language model (LLM) artificial intelligence (AI) system can match, or in some cases outperform, human ophthalmologists in the diagnosis and treatment of patients with glaucoma and retina disease, according to research from New York Eye and Ear Infirmary of Mount Sinai (NYEE).
Gilead and Genesis partner to create novel therapies using AI
Gilead holds sole rights for clinical development and potential commercialisation of the compounds developed under the deal. Credit: JHVEPhoto/Shutterstock. Gilead Sciences has announced a strategic